SecondWave Systems is developing a noninvasive, wearable ultrasound stimulation platform that utilizes low-intensity focused ultrasound (LiFU) to modulate neural and cellular pathways for the treatment of conditions such as inflammation and pain. This technology offers patients an alternative to costly medications with side effects, enabling in-home self-administration and reducing the need for frequent medical visits.
Funding
$3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
ARFounders
Product
Problem
Many conditions, such as inflammation and pain, are treated with medications that can be costly and cause undesirable side effects. Current treatment options often require frequent medical visits, creating inconvenience and potential burdens for patients.
Solution
SecondWave Systems is developing a wearable, noninvasive ultrasound stimulation platform that utilizes low-intensity focused ultrasound (LiFU) to modulate neural and cellular pathways. This technology offers a novel approach to treating conditions by providing an alternative to traditional medications. The miniaturized form factor allows for convenient in-home self-administration, potentially augmenting existing treatments and reducing the need for frequent office visits. Proprietary sensing and imaging capabilities enable adaptive and personalized therapy.
Target Audience
The primary target audience includes patients seeking alternative treatments for conditions like inflammation and pain, as well as physicians looking for non-pharmacological options for their patients.
Features
- Noninvasive low-intensity focused ultrasound (LiFU) technology for targeted modulation of nerves, cells, and organs.
- Wearable form factor designed for convenient in-home self-administration.
- Adaptive therapy enabled by proprietary sensing and imaging capabilities.
- Potential applications for treating inflammation, pain, and other disorders.